Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

FDA Promotes Personalized Medicine

Nov 8, 2013

FDA Promotes Personalized Medicine

Generic Drug Super Office Takes Shape

Nov 8, 2013

Generic Drug Super Office Takes Shape

Breakthrough Therapies Raise Manufacturing Issues

Nov 8, 2013

Breakthrough Therapies Raise Manufacturing Issues

FDA Moves to Curb Drug Shortages

Nov 8, 2013

FDA Moves to Curb Drug Shortages

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Nov 2, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

FDA Updates Foreign Operations

Oct 4, 2013

Budget issues and changing global markets are prompting FDA to revise its growing network of overseas offices.

FDA Seeks Metrics to Define Drug Quality

Manufacturing standards are considered key to preventing drug recalls and shortages.
Oct 2, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

FDA Works to Secure Drug Supply Chain

New policies aim to strengthen inspection and oversight processes.
Sep 2, 2013

New FDA supply chain policies aim to strengthen inspection and oversight processes.

Regulatory Roundup

Aug 2, 2013

Appropriate use of medications promises to improve patient care and curb spending, prompting pharmacists, public health authorities, and manufacturers to promote multiple adherence strategies.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here